All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @agelessmenshealth on Instagram · 100s|Watch on Instagram
Full video transcriptClick to expand

Auto-generated transcript of @agelessmenshealth's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00Hi, Alex from Ageless Men's Health Today.
  2. 0:03I want to discuss the key differences between oral and injectable testosterone replacement
  3. 0:08therapies as highlighted in this article here behind me.
  4. 0:12Oral testosterone is typically taken twice daily.
  5. 0:15However, its absorption can be inconsistent and is significantly affected by food intake,
  6. 0:21requiring careful meal planning to maintain stable hormone levels.
  7. 0:26Oral testosterone is intramuscularly administered, often on a weekly or biweekly basis.
  8. 0:33This method provides a more stable and sustained testosterone level, which can lead to more
  9. 0:38consistent symptom relief.
  10. 0:41Injections also bypass the digestive system, reducing potential liver strain associated
  11. 0:47with oral medications.
  12. 0:48And while both forms aim to restore testosterone levels, injectable testosterone has been widely
  13. 0:55used and studied with a well-established safety and efficacy profile.
  14. 1:00Oral testosterone formulations are newer and may carry risks related to variable absorption
  15. 1:06and potential liver effects.
  16. 1:09Choosing the appropriate testosterone replacement therapy is a personalized decision that should
  17. 1:14be made in consultation with a healthcare provider.
  18. 1:17At Ageless, we are committed to guiding you through this process to determine the most
  19. 1:22suitable and safe option for your needs.
  20. 1:26If you're experiencing symptoms of low testosterone, contact us today and schedule a consultation.
  21. 1:31Let's work together to find the best treatment approach for you.

@agelessmenshealth's testosterone delivery claims, fact-checked

Ageless Men's Health® | TRT & Weight Loss Experts

Instagram creator

11.2K viewsView on Instagram

Quick answer

The video compares oral testosterone undecanoate to injectable testosterone cypionate or enanthate for hypogonadism treatment, correctly noting food-dependent absorption for oral formulations and stable serum levels with intramuscular injections. The liver strain argument presented in the video applies to older 17-alpha alkylated oral androgens, not to FDA-approved testosterone undecanoate, which has not demonstrated clinically significant hepatotoxicity in phase III trials. Both delivery methods are legitimate options for appropriately diagnosed hypogonadal patients, with selection driven by lifestyle factors, patient preference, and clinical monitoring capacity.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 8 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @agelessmenshealth's testosterone delivery claims, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

@agelessmenshealth's testosterone delivery claims, fact-checked is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@agelessmenshealth's testosterone delivery claims, fact-checked" from Ageless Men's Health® | TRT & Weight Loss Experts. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The video compares oral testosterone undecanoate to injectable testosterone cypionate or enanthate for hypogonadism treatment, correctly noting food-dependent absorption for oral formulations and stable serum levels with intramuscular injections.

The reason this review is not generic is the source wording and the canonical claim label "trt oral vs injectable testosterone which is right for you." In this clip, the useful excerpt is: "Hi, Alex from Ageless Men's Health Today." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Swerdloff et al.
People who land here are usually comparing the Testosterone claim with LowT, TestosteroneTherapy, and TRT.
The strongest next step is to compare the claim with FormBlends' Testosterone guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The video compares oral testosterone undecanoate to injectable testosterone cypionate or enanthate for hypogonadism treatment, correctly noting food-dependent absorption for oral formulations and stable serum levels with intramuscular injections.

FormBlends verdict

Testosterone evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The video compares oral testosterone undecanoate to injectable testosterone cypionate or enanthate for hypogonadism treatment, correctly noting food-dependent absorption for oral formulations and stable serum levels with intramuscular injections. The liver strain argument presented in the video applies to older 17-alpha alkylated oral androgens, not to FDA-approved testosterone undecanoate, which has not demonstrated clinically significant hepatotoxicity in phase III trials. Both delivery methods are legitimate options for appropriately diagnosed hypogonadal patients, with selection driven by lifestyle factors, patient preference, and clinical monitoring capacity.
  • FDA-approved oral testosterone undecanoate (Jatenzo, Tlando) is not the same as older alkylated oral androgens; the liver toxicity risk commonly cited does not apply to the current approved formulations per Swerdloff et al. (2020, JCEM).
  • Swerdloff et al. (2020) found oral testosterone undecanoate achieved therapeutic serum levels in approximately 87% of men, with food-dependent absorption being manageable rather than prohibitive.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • FDA-approved oral testosterone undecanoate (Jatenzo, Tlando) is not the same as older alkylated oral androgens; the liver toxicity risk commonly cited does not apply to the current approved formulations per Swerdloff et al. (2020, JCEM).
  • Swerdloff et al. (2020) found oral testosterone undecanoate achieved therapeutic serum levels in approximately 87% of men, with food-dependent absorption being manageable rather than prohibitive.
  • The video contains a clear factual error: Alex states oral testosterone is intramuscularly administered, which reverses the actual route of administration.
  • Bhasin et al. (2010, NEJM) established that intramuscular testosterone injections produce stable trough levels with weekly or biweekly dosing, supporting the stability claim for injectables.
  • Khera et al. (2022, Urology Clinics of North America) concluded that both oral and injectable testosterone can achieve symptom relief in hypogonadal patients, with delivery method selection driven by patient lifestyle and preference.
  • The twice-daily dosing requirement and meal timing for oral testosterone undecanoate are real practical considerations, but they are management factors, not evidence of inferiority to injectables.
  • Neither oral nor injectable testosterone is appropriate without a confirmed diagnosis of hypogonadism through clinical evaluation and laboratory testing.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @agelessmenshealth actually say?

Alex from Ageless Men's Health walked through the differences between oral and injectable testosterone, leaning hard toward injectables. He said oral testosterone has "inconsistent" absorption tied to food intake, while injections provide "more stable and sustained testosterone levels." He also claimed injections "bypass the digestive system, reducing potential liver strain" and that oral formulations are newer with less established safety data. The video ends with a call to schedule a consultation.

That's a fairly reasonable overview, but there's a specific factual error buried in the middle that undermines the whole segment, and the liver claim is more nuanced than he lets on.

Does the science back this up?

Partially. The absorption variability claim for oral testosterone is real, but the liver strain framing is outdated and doesn't apply cleanly to modern oral formulations. Injectable testosterone's efficacy profile is well-documented, but calling oral options categorically riskier is a stretch given current evidence.

Testosterone undecanoate (Jatenzo, Tlando, Kyzaiq) is the primary oral formulation approved in the U.S. These are not 17-alpha alkylated compounds, which is the older class of oral androgens actually linked to hepatotoxicity. Swerdloff et al. (2020, Journal of Clinical Endocrinology and Metabolism) showed that oral testosterone undecanoate achieved therapeutic serum levels in roughly 87% of men, with meal-dependent absorption being a real but manageable variable. The liver signal in that trial was not clinically significant.

For injectables, the evidence base is stronger simply because testosterone cypionate and enanthate have been used for decades. Bhasin et al. (2010, NEJM) remains a key reference for injectable testosterone's efficacy in hypogonadal men, confirming stable trough levels with weekly or biweekly dosing.

What did they get wrong (or right)?

There is a clear scripting error in this video that should not go unaddressed. Alex says "oral testosterone is intramuscularly administered" when he visibly means to say injectable testosterone. That is a factual mix-up that could genuinely confuse viewers who are early in researching TRT options.

On the liver claim: the framing that injectables reduce "liver strain associated with oral medications" is misleading when applied to FDA-approved oral testosterone undecanoate. That liver risk narrative comes from older, alkylated oral androgens like methyltestosterone, which are largely off the market. Saying modern oral testosterone carries liver risk without that distinction is not accurate.

What he got right: food-dependent absorption for oral testosterone undecanoate is real and documented. The FDA label for Jatenzo specifically requires administration with food. He also appropriately deferred to healthcare providers for treatment decisions, which is the correct call.

What should you actually know?

If you are comparing oral and injectable testosterone, the actual decision points are more practical than the video suggests. Injection frequency, needle comfort, and consistent scheduling matter for injectables. Meal timing and the twice-daily dosing schedule matter for oral options. Neither form is universally superior.

The liver concern is largely a non-issue with approved oral testosterone undecanoate at therapeutic doses, based on current trial data. If a provider or content creator is still invoking the liver argument to steer you away from oral testosterone, ask them specifically which formulation they mean. Alkylated oral androgens and modern testosterone undecanoate are not the same thing.

A 2022 review by Khera et al. in Urology Clinics of North America noted that both delivery methods can achieve symptom relief in hypogonadal men when dosed appropriately, and that patient preference and lifestyle factors should be weighted heavily in the choice. That is a more accurate frame than "injectables are more stable, therefore better."

  • Oral testosterone undecanoate is FDA-approved and does not carry the same hepatotoxicity risk as older alkylated oral androgens.
  • Injectable testosterone has a longer evidence base, but that reflects history of availability, not inherent superiority.
  • Absorption variability with oral TRT is real, but manageable with consistent meal timing.
  • The "intramuscularly administered" line in the video was a scripting error that reversed the route of administration.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Ageless Men's Health® | TRT & Weight Loss Experts · Instagram creator

11.2K views on this video

Oral vs. Injectable Testosterone—Which is Right for You? 💉💊 Oral testosterone requires careful meal timing and can have inconsistent absorption, while injectable testosterone delivers more stable,

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about fda-approved?

FDA-approved oral testosterone undecanoate (Jatenzo, Tlando) is not the same as older alkylated oral androgens; the liver toxicity risk commonly cited does not apply to the current approved formulations per Swerdloff et al. (2020, JCEM).

What does the video say about swerdloff et al. (2020) found?

Swerdloff et al. (2020) found oral testosterone undecanoate achieved therapeutic serum levels in approximately 87% of men, with food-dependent absorption being manageable rather than prohibitive.

What does the video say about the video contains a clear factual error: alex states?

The video contains a clear factual error: Alex states oral testosterone is intramuscularly administered, which reverses the actual route of administration.

What does the video say about bhasin et al. (2010, nejm) established?

Bhasin et al. (2010, NEJM) established that intramuscular testosterone injections produce stable trough levels with weekly or biweekly dosing, supporting the stability claim for injectables.

What does the video say about khera et al. (2022, urology clinics of north america) concluded?

Khera et al. (2022, Urology Clinics of North America) concluded that both oral and injectable testosterone can achieve symptom relief in hypogonadal patients, with delivery method selection driven by patient lifestyle and preference.

What does the video say about the twice-daily dosing requirement?

The twice-daily dosing requirement and meal timing for oral testosterone undecanoate are real practical considerations, but they are management factors, not evidence of inferiority to injectables.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Ageless Men's Health® | TRT & Weight Loss Experts, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.